Cyclerion Therapeutics, Inc. Recorded Big Gain
Tue, May 16, 2023 at 07:42 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) shot up at $5.38, representing a gain of 40.7%. On Tue, May 16, 2023, CYCN:NASDAQ hit a New 2-Week High of $5.38. The stock got featured on our News Catalysts scanner on Mon, May 15, 2023 at 01:59 PM in the 'SPLIT' category. From Tue, May 02, 2023, the stock recorded 60.00% Up Days and 63.64% Green Days
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Exela Technologies, Inc. (XELA:NASDAQ), 103.9%
- Missfresh Limited (MF:NASDAQ), 50.29%
- GD Culture Group Ltd Com (New) (GDC:NASDAQ), 45.85%
- The Singing Machine Company Inc. (MICS:NASDAQ), 41.9%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 40.69%
- SRAX, Inc. (SRAX:NASDAQ), 36.54%
- AN2 Therapeutics Inc. (ANTX:NASDAQ), 35.96%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 33.33%
- VivoPower International PLC (VVPR:NASDAQ), 30.76%
- United Insurance Holdings Corp. (UIHC:NASDAQ), 29.58%